NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia
Mateon and PointR to merge into AI-driven oncology firm
Mateon | HealthWire
iBio Announces Collaboration with EdgePoint AI for Next Gen Biologics Manufacturing - DATAVERSITY
Combined CA4P (Fosbretabulin) therapy in Cancer- Ashini R. Dias, Contributor | Cancer Biology
Mateon launches antiviral programme focussed on Covid-19
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
Mateon Therapeutics (MATN) expands its management team to accelerate the commercialization and development of OT-101 for COVID-19 - EmergingGrowth.com
Mateon Therapeutics Archives - IndiaMedToday
A Covid-19 treatment plan slowly emerges | Evaluate
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Mateon Therapeutics
EDGAR Filing Documents for 0001493152-21-001207
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
COVID Pandemic Hastens Search For New Technology And CRO Partner
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
Zacks Small-Cap Research
Articles about Mateon Therapeutics, Inc.
Corporate Videos – Oncotelic
EX-4.1
